Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VTYX Investor Notice: Levi & Korsinsky Investigates Ventyx Biosciences, Inc. for Securities Law Violations

accessnewswire.com
VTYX Levi & Korsinsky is investigating Ventyx Biosciences for securities law violations following a significant stock price drop after the company revised its data release timeline and expanded its trial locations. This suggests potential issues with the company's disclosures or trial progress.

NEW YORK, NY / ACCESS Newswire / December 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Ventyx Biosciences, Inc. ("Ventyx Biosciences, Inc.") (NASDAQ:VTYX) concerning possible violations of federal securities laws.

Ventyx issued a press release on December 2, 2025, "providing an update to its ongoing Phase 2 study of VTX2735 in patients with recurrent pericarditis (‘RP')." In relevant part, the Company's Chief Executive Officer said that "[w]e are . . . revising our guidance for topline data release from the interim analysis of the Phase 2 RP trial to Q1 2026," describing the shift as "providing us with an opportunity to introduce dose-ranging studies with our new once-daily or QD formulation in the current Phase 2 study while also expanding into Canada, EU and the UK, a strategy we feel will accelerate Phase 3 timelines."

Following this news, Ventyx's stock price fell over 15% on December 2, 2025. To obtain additional information, go to:

https://zlk.com/pslra-1/ventyx-biosciences-inc-lawsuit-submission-form-2?prid=180022&wire=1&utm_campaign=63

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212)363-7500

Fax: (212)363-7171

https://zlk.com/

SOURCE: Levi & Korsinsky, LLP